Literature DB >> 22130733

Amphotericin B/sterol co-loaded PEG-phospholipid micelles: effects of sterols on aggregation state and hemolytic activity of amphotericin B.

Thomas A Diezi1, Glen Kwon.   

Abstract

PURPOSE: To elucidate the effect of sterols on the aggregation of amphotericin B (AmB) in PEG-phospholipid micelles and its consequences on the hemolytic activity of AmB.
METHODS: AmB-incorporated PEG-phospholipid micelles co-loaded with ergosterol, cholesterol, or 7-dehydrocholesterol were prepared at 4:1:1 and 20:5:1 ratios of polymer-to-sterol-to-AmB. The aggregation state of AmB was elucidated by UV-vis spectroscopy. AmB/sterol co-loaded PEG-phospholipid micelles were incubated with red blood cells and the hemolytic activity of AmB assessed by measurement of free hemoglobin.
RESULTS: AmB in PEG-phospholipid micelles stayed mostly in a deaggregated state in the absence of sterol or with cholesterol, but aggregated in the presence of ergosterol or 7-dehydrocholesterol. The fraction of aggregated AmB in PEG-phospholipid micelles was lower at the 20:5:1 ratio. In an aggregated state or in the absence of sterol, AmB caused rapid and complete hemolysis. In contrast, deaggregated AmB co-loaded with cholesterol caused slower and incomplete hemolysis, especially at a 20:5:1 ratio.
CONCLUSIONS: The aggregation state of AmB in PEG-phospholipid micelles was sterol dependant. AmB/cholesterol co-loaded PEG-phospholipid micelles caused low in vitro hemolysis due to deaggregation of AmB and micellar stability, presumably owing to cholesterol/phospholipid versus cholesterol/AmB interactions in the interior core region.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130733      PMCID: PMC4624226          DOI: 10.1007/s11095-011-0626-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Dimers of polyene antibiotic amphotericin B detected by means of fluorescence spectroscopy: molecular organization in solution and in lipid membranes.

Authors:  Wiesław I Gruszecki; Mariusz Gagoś; Monika Hereć
Journal:  J Photochem Photobiol B       Date:  2003-01       Impact factor: 6.252

2.  Effect of aggregation of amphotericin B on lysophosphatidylcholine micelles as related to its complex formation with cholesterol or ergosterol.

Authors:  M Kawabata; M Onda; T Mita
Journal:  J Biochem       Date:  2001-05       Impact factor: 3.387

3.  Enhanced stability of PEG-block-poly(N-hexyl stearate l-aspartamide) micelles in the presence of serum proteins.

Authors:  Thomas A Diezi; Younsoo Bae; Glen S Kwon
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

4.  The interactions of amphotericin B with various sterols in relation to its possible use in anticancer therapy.

Authors:  C Charbonneau; I Fournier; S Dufresne; J Barwicz; P Tancrède
Journal:  Biophys Chem       Date:  2001-07-02       Impact factor: 2.352

5.  Effect of cholesterol on the release of amphotericin B from PEG-phospholipid micelles.

Authors:  Ronak Vakil; Glen S Kwon
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

6.  Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs.

Authors:  Ho-Chul Shin; Adam W G Alani; Deepa A Rao; Nicole C Rockich; Glen S Kwon
Journal:  J Control Release       Date:  2009-05-04       Impact factor: 9.776

7.  In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta benzyl L aspartate) micelles.

Authors:  B G Yu; T Okano; K Kataoka; S Sardari; G S Kwon
Journal:  J Control Release       Date:  1998-12-04       Impact factor: 9.776

8.  In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation.

Authors:  Beena Ashok; Lise Arleth; Rex P Hjelm; Israel Rubinstein; Hayat Onyüksel
Journal:  J Pharm Sci       Date:  2004-10       Impact factor: 3.534

9.  Theoretical study of the complexation of amphotericin B with sterols.

Authors:  J Langlet; J Bergès; J Caillet; J P Demaret
Journal:  Biochim Biophys Acta       Date:  1994-04-20

10.  Combination antifungal therapy involving amphotericin B, rapamycin and 5-fluorocytosine using PEG-phospholipid micelles.

Authors:  Ronak Vakil; Kayla Knilans; David Andes; Glen S Kwon
Journal:  Pharm Res       Date:  2008-04-16       Impact factor: 4.580

View more
  5 in total

1.  Antifungal Efficacy of an Intravenous Formulation Containing Monomeric Amphotericin B, 5-Fluorocytosine, and Saline for Sodium Supplementation.

Authors:  Celeste Alvarez; David R Andes; Jeong Yeon Kang; Carmen Krug; Glen S Kwon
Journal:  Pharm Res       Date:  2017-02-15       Impact factor: 4.200

2.  Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.

Authors:  Celeste Alvarez; Dae Hwan Shin; Glen S Kwon
Journal:  Pharm Res       Date:  2016-05-19       Impact factor: 4.200

Review 3.  Polyene Antibiotics Physical Chemistry and Their Effect on Lipid Membranes; Impacting Biological Processes and Medical Applications.

Authors:  Tammy Haro-Reyes; Lucero Díaz-Peralta; Arturo Galván-Hernández; Anahi Rodríguez-López; Lourdes Rodríguez-Fragoso; Iván Ortega-Blake
Journal:  Membranes (Basel)       Date:  2022-06-30

4.  Fungal Infected Adipose Stem Cells: The Effects of Novel Lipo-Niosome Nanoparticles Loaded with Amphotericin B and Thymus Essential Oil.

Authors:  Fardin Rahimi; Ghasem Amoabediny; Hossein Sabahi; Behrouz Zandieh-Doulabi
Journal:  Cell J       Date:  2022-07-27       Impact factor: 3.128

Review 5.  Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments.

Authors:  Daniel Michał Kamiński
Journal:  Eur Biophys J       Date:  2014-08-31       Impact factor: 1.733

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.